Contact

John Bondo Hansen
jbha@conrigpharma.com


Mikael Thomsen
mst@conrigpharma.com

 

Niels Skjærbæk

ns@conrigpharma.com

Founders

John Bondo Hansen


PhD in medicinal chemistry. More than 30 years experience in pharma and biotech. CEO. 


Mikael Thomsen


Ph.D. in Pharmacology & Toxicology, More than 15 years experience in pharma and biotech. CSO.

Conrig Pharma develops drugs with attractive safety and efficacy profiles to provide new treatments of serious illnesses.

Initial focus will be on development of ST-015 for treatment of serious respiratory disorders. ST-015 could enter Phase IIa clinical studies in late 2018.